Arrivent Biopharma Inc
AVBP18.780USD
+0.120+0.64%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
18.780USD+18.780After-hours (ET)
639.29MMarket Cap
LossP/E TTM
Arrivent Biopharma Inc
18.780
+0.120+0.64%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
Total equity
Cash, cash equivalents and short-term investments
-44.52%176.08M
45.53%218.86M
70.03%282.86M
63.36%298.67M
--317.39M
--150.39M
--166.36M
--182.83M
- Cash and cash equivalents
-84.29%49.87M
-50.60%74.29M
100.10%282.86M
89.23%298.67M
--317.39M
--150.39M
--141.36M
--157.83M
-Short-term investments
--126.21M
--144.57M
----
----
----
----
--25.00M
--25.00M
Receivables
-42.29%505.00K
-34.30%500.00K
-54.09%500.00K
190.70%750.00K
--875.00K
--761.00K
--1.09M
--258.00K
-Other receivables
----
----
----
----
----
----
--456.00K
----
Prepaid expenses
-27.68%303.00K
-2.92%233.00K
406.67%684.00K
91.24%480.00K
--419.00K
--240.00K
--135.00K
--251.00K
Other current assets
1.22%8.90M
-13.93%7.38M
-32.57%8.36M
-43.87%8.61M
--8.79M
--8.58M
--12.40M
--15.34M
Total current assets
-43.27%185.78M
41.89%226.98M
62.46%292.40M
55.28%308.51M
--327.48M
--159.97M
--179.98M
--198.69M
Non-current assets
Net Fixed Assets
-52.00%120.00K
-47.08%154.00K
325.00%187.00K
188.16%219.00K
--250.00K
--291.00K
--44.00K
--76.00K
Other non-current assets
62.96%176.00K
-95.56%126.00K
-93.58%126.00K
52.44%125.00K
--108.00K
--2.84M
--1.96M
--82.00K
Total non-current assets
8198.88%29.71M
1432.36%47.96M
-84.40%313.00K
117.72%344.00K
--358.00K
--3.13M
--2.01M
--158.00K
Total assets
-34.27%215.50M
68.57%274.94M
60.84%292.71M
55.33%308.86M
--327.84M
--163.10M
--181.99M
--198.84M
Liabilities
Current liabilities
-Other payables
--0.00
----
----
----
----
----
----
----
Accrued expenses
47.44%8.45M
91.74%13.33M
97.77%10.36M
29.54%8.13M
--5.73M
--6.95M
--5.24M
--6.28M
Other current liabilities
--0.00
----
----
----
----
----
----
----
Total current liabilities
29.83%12.95M
48.61%17.27M
50.12%15.16M
-5.58%12.10M
--9.98M
--11.62M
--10.10M
--12.81M
Non-current liabilities
Long-term debt and lease liabilities
-100.00%0.00
-92.09%14.00K
--56.00K
--98.00K
--138.00K
--177.00K
--0.00
--0.00
-Long-term lease liabilities
-100.00%0.00
-92.09%14.00K
--56.00K
--98.00K
--138.00K
--177.00K
--0.00
--0.00
Other non-current liabilities
--0.00
----
----
----
----
----
----
----
Total non-current liabilities
-100.00%0.00
-92.09%14.00K
--56.00K
--98.00K
--138.00K
--177.00K
--0.00
--0.00
Total liabilities
28.06%12.95M
46.50%17.29M
50.67%15.22M
-4.82%12.20M
--10.12M
--11.80M
--10.10M
--12.81M
Shareholders' equity
Common equity
2.49%505.28M
10566.34%496.20M
11820.87%495.19M
12922.02%493.80M
--492.99M
--4.65M
--4.15M
--3.79M
Preferred equity
----
----
----
----
----
--304.49M
--304.49M
--304.49M
Retained earnings
-72.72%-302.72M
-50.99%-238.33M
-59.31%-217.70M
-61.26%-197.14M
---175.26M
---157.84M
---136.65M
---122.25M
Capital reserves
2.49%505.27M
10566.27%496.19M
11820.80%495.19M
12935.69%493.79M
--492.98M
--4.65M
--4.15M
--3.79M
Gains losses not affecting retained earnings
---17.00K
---211.00K
----
----
----
----
----
----
Total equity
-36.25%202.54M
70.30%257.65M
61.44%277.49M
59.47%296.66M
--317.72M
--151.30M
--171.89M
--186.03M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
